# Norepinephrine vs Norepinephrine and Dobutamine in Cardiogenic Shock

> **NCT03340779** · PHASE3 · UNKNOWN · sponsor: **Central Hospital, Nancy, France** · enrollment: 40 (estimated)

## Conditions studied

- Cardiogenic Shock

## Interventions

- **DRUG:** Norepinephrine

## Key facts

- **NCT ID:** NCT03340779
- **Lead sponsor:** Central Hospital, Nancy, France
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-01-15
- **Primary completion:** 2019-11-01
- **Final completion:** 2020-05-01
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2017-11-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03340779

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03340779, "Norepinephrine vs Norepinephrine and Dobutamine in Cardiogenic Shock". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT03340779. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*